Skip to content
  • 6,809 federal solicitations are open right now. How many of them are yours?
  • New solicitations are posted every day. The ones you never saw are the ones you cannot win.
  • Stop checking SAM.gov every morning. Let the contracts that fit your business come to you.
  • Tell Abierto what you sell in one sentence. AI reads every open solicitation for you.
  • Deadlines are short. Hear about a solicitation the day it is posted, not the week it closes.
  • Amendments move deadlines. Watch a solicitation and Abierto tells you when it changes.
  • See which contracts in your field are about to end, and who holds them today.
  • Plans from $39 a month. See your matches before you pay.
See plans
AbiertoGet started
Menu

Award notice

Intent to Sole Source Ga68 Dotate NETSPOT base plus 4 Option Years

36C24725P0868

Department of Veterans Affairs, 247-Network Contract Office 7. In-Vitro Diagnostic Substance Manufacturing.

13 open like this View on SAM.gov Markdown

Awarded

Cardinal Health, Inc. Dublin

$302,250.00 on the award notice, October 1, 2025, contract 36C24725P0868

Get the next one like this from Department of Veterans Affairs by email, the day it is posted.Find my opportunities

This one was awarded in 2025

13 like it are open now in in-vitro diagnostic substance manufacturing

All 13 open in in-vitro diagnostic substance manufacturing

Description

As published on SAM.gov.

INTENT TO SOLE SOURCE NOTICE

Estimated Date of Award:

1 Oct, 2025 Synopsis: Department of Veterans Affairs (VA) Network Contracting Office 7 (NCO 7) intends to award a sole source contract award to Cardinal Health, Inc., 7000 Cardinal Pl. Dublin, OH 43017-1091. The period of performance for contract award will be from October 1, 2025 through September 30, 2030. This requirement is for the purchase of Ga-68 Dotatate Netspot injectable Positron Emission Tomography imaging (PET) to identify suspected tumors in the body.

Ga-68 Netspot is a PET/CT imaging radiopharmaceutical for the localization of somatostatin receptor positive neuroendocrine tumors. This injectable drug is a molecular imaging agent used in Positron Emission Tomography (PET) imaging to identify suspected NET tumors anywhere in the body.

This will be a new firm fixed price contract supporting the Charlie Norwood VA Medical Center, located at 1 Freedom Way, Augusta, GA 30904. THIS NOTICE IS NOT A REQUEST FOR COMPETITIVE QUOTES; however, any firm that believes it can meet the requirements may give written notification prior to the response due date and time. Supporting evidence must be furnished in sufficient detail to demonstrate the ability to perform the requirements.

Responses received will be evaluated; however, a determination by the Government not to compete the proposed procurement based upon responses to this notice is solely within the discretion of the Government. If no responses are received, the Government will proceed with the award. Responses are due by July 25, 2025 at 11:00 a.m. (ET). Responses shall be submitted via e-mail to Michael.barton@va.gov. Telephone requests or inquires will not be accepted.

System for Award Management (SAM): Rule requires a firm to be registered in the SAM Registration Database (SAM) prior to award of any contract and agreements. Firms must register on an on-time basis, and annually confirm accuracy and completeness of registration information. To register in SAM go to:

https://www.sam.gov/portal/public/SAM

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. June 25, 2025

    Award notice

    Awarded to Cardinal Health, Inc. Dublin for $302,250. SAM.gov, notice 4e4ea9e0322e486aa0138fe3cff79e52

Points of contact